AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 153 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $9,292,000 | -21.3% | 388,458 | -10.3% | 0.01% | -9.1% |
Q3 2018 | $11,812,000 | +2.3% | 432,976 | +0.8% | 0.01% | 0.0% |
Q2 2018 | $11,550,000 | -14.0% | 429,534 | +1.8% | 0.01% | -15.4% |
Q1 2018 | $13,428,000 | +164.5% | 421,866 | +110.4% | 0.01% | +160.0% |
Q3 2015 | $5,077,000 | – | 200,503 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,967,900 | $42,933,000 | 29.35% |
TLP GROUP LLC | 2,833,285 | $30,656,000 | 20.86% |
Aisling Capital LLC | 2,990,000 | $32,352,000 | 7.64% |
Vivo Capital, LLC | 763,009 | $8,256,000 | 2.26% |
RA Capital Management | 1,292,940 | $13,990,000 | 1.94% |
Foresite Capital Management III, LLC | 235,020 | $2,543,000 | 1.74% |
Palo Alto Investors LP | 325,599 | $3,523,000 | 0.27% |
Rock Springs Capital Management LP | 293,000 | $3,170,000 | 0.24% |
EMERALD MUTUAL FUND ADVISERS TRUST | 332,625 | $3,599,000 | 0.20% |
Virtus ETF Advisers LLC | 19,501 | $211,000 | 0.16% |